Recognition of UAG termination codon by mammalian tyrosine tRNA containing 6-thioqueuine in the first position of the anticodon.
スポンサーリンク
概要
著者
-
Shindo-okada Nobuko
Biology Division National Cancer Center Research Institute
-
Nishimura Susumu
Biology Division National Cancer Center Research Institute
-
NOMURA Hiroaki
Central Research Division, Takeda Chemical Industries, Ltd.
-
AKIMOTO Hiroshi
Central Research Laboratories, Takeda Chemical Ind., Ltd.
関連論文
- Establishment of Cell Lines with High and Low Metastatic Potential from A549 Human Lung Adenocarcinoma
- Establishment of Cell Lines with High-and Low-metastatic Potential from PC-14 Human Lung Adenocarcinoma
- CLc3 A NOVEL LYSINE-SUBSTITUTED NUCLEOSIDE IN THE FIRST POSITION OF THE ANTICODON OF MINOR ISOLEUCINE tRNA FROM Escherichia coli
- Characterization of the activity of a platelet activating factor antagonist, CV-3988.
- Restriction fragment length polymorphism(RFLP) of L-myc is related to the progression of human colon and stomach cancers.
- Chemical synthesis of 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ), a potent mutagen isolated from broiled fish.
- Potent novel mutagens produced by broiling fish under normal conditions.
- Recognition of UAG termination codon by mammalian tyrosine tRNA containing 6-thioqueuine in the first position of the anticodon.
- Preparation and characterization of monoclonal antibodies for the modified base, queuine.
- Syntheses of 2-amino-3,4-dimethyl-3H-imidazo(4,5-f)quinoline and its related compounds.